Case Reports Study on Methanol Poisoning in King Abdul Aziz Specialist Hospital, Taif, Saudi Arabia
Abstract
:1. Introduction
2. Material and Method
2.1. Cases Presentation
2.2. Final Diagnosis
Treatment
2.3. Follow-Up and Outcome
3. Discussion
4. Limitations and Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Mégarbane, B.; Borron, S.W.; Baud, F.J. Current recommendations for treatment of severe toxic alcohol poisonings. Intensive Care Med. 2005, 31, 189–195. [Google Scholar] [CrossRef]
- Kraut, J.A.; Kurtz, I. Toxic alcohol ingestions: Clinical features, diagnosis, and management. Clin. J. Am. Soc. Nephrol. 2008, 3, 208–225. [Google Scholar] [CrossRef] [Green Version]
- Galvez-Ruiz, A.; Elkhamary, S.M.; Asghar, N.; Bosley, T.M. Visual and neurologic sequelae of methanol poisoning in Saudi Arabia. Saudi Med. J. 2015, 36, 568–574. [Google Scholar] [CrossRef]
- Manning, L.; Kowalska, A. Illicit alcohol: Public health risk of methanol poisoning and policy mitigation strategies. Foods 2021, 10, 1625. [Google Scholar] [CrossRef] [PubMed]
- Edenberg, H.J. The genetics of alcohol metabolism: Role of alcohol dehydrogenase and aldehyde dehydrogenase variants. Alcohol Res. Health 2007, 30, 5–13. [Google Scholar]
- Gouda, A.S.; Khattab, A.M.; Mégarbane, B. Lessons from a methanol poisoning outbreak in Egypt: Six case reports. World J. Crit. Care Med. 2020, 9, 54. [Google Scholar] [CrossRef]
- Kraut, J.A.; Mullins, M.E. Toxic Alcohols. N. Engl. J. Med. 2018, 378, 270–280. [Google Scholar] [CrossRef]
- Paasma, R.; Hovda, K.E.; Jacobsen, D. Methanol poisoning and long term sequelae 2014—A six years follow-up after a large methanol outbreak. BMC Clin. Pharm. 2009, 9, 5. [Google Scholar] [CrossRef] [Green Version]
- Hovda, K.E.; Hunderi, O.H.; Tafjord, A.B.; Dunlop, O.; Rudberg, N.; Jacobsen, D. Methanol outbreak in Norway 2002–2004: Epidemiology, clinical features and prognostic signs. J. Intern. Med. 2005, 258, 181–190. [Google Scholar] [CrossRef]
- Moon, C.-S. Estimations of the lethal and exposure doses for representative methanol symptoms in humans. Ann. Occup. Environ. Med. 2017, 29, 44. [Google Scholar] [CrossRef]
- Nekoukar, Z.; Zakariaei, Z.; Taghizadeh, F.; Musavi, F.; Banimostafavi, E.S.; Sharifpour, A.; Ebrahim Ghuchi, N.; Fakhar, M.; Tabaripour, R.; Safanavaei, S. Methanol poisoning as a new world challenge: A review. Ann. Med. Surg. 2021, 66, 102445. [Google Scholar] [CrossRef]
- Roberts, D.M.; Yates, C.; Megarbane, B.; Winchester, J.F.; Maclaren, R.; Gosselin, S.; Nolin, T.D.; Lavergne, V.; Hoffman, R.S.; Ghannoum, M. Recommendations for the role of extracorporeal treatments in the management of acute methanol poisoning: A systematic review and consensus statement. Crit. Care Med. 2015, 43, 461–472. [Google Scholar] [CrossRef]
- Hassanian-Moghaddam, H.; Nikfarjam, A.; Mirafzal, A.; Saberinia, A.; Nasehi, A.A.; Masoumi Asl, H.; Memaryan, N. Methanol mass poisoning in Iran: Role of case finding in outbreak management. J. Public Health 2015, 37, 354–359. [Google Scholar] [CrossRef] [Green Version]
- Hovda, K.E.; Hunderi, O.H.; Rudberg, N.; Froyshov, S.; Jacobsen, D. Anion and osmolal gaps in the diagnosis of methanol poisoning: Clinical study in 28 patients. Intensive Care Med. 2004, 30, 1842–1846. [Google Scholar] [CrossRef] [PubMed]
- Martín-Calderón, J.L.; Bustos, F.; Tuesta-Reina, L.R.; Varona, J.M.; Caballero, L.; Solano, F. Choice of the best equation for plasma osmolality calculation: Comparison of fourteen formulae. Clin. Biochem. 2015, 48, 529–533. [Google Scholar] [CrossRef]
- Shafi, H.; Imran, M.; Usman, H.F.; Sarwar, M.; Tahir, M.A. Eight fatalities due to drinking methanol-tainted alcohol in Pakistan: A case report. Egypt. J. Forensic Sci. 2016, 6, 515–519. [Google Scholar] [CrossRef] [Green Version]
- Rahimi, R.; Zainun, K.A.; Noor, N.M.; Kasim, N.A.M.; Shahrir, N.F.; Azman, N.A.; Elankopan, R.; Nikman, K.A.; Room, N.H.M. Methanol poisoning in Klang Valley, Malaysia: Autopsy case series. Forensic Sci. Int. Rep. 2021, 3, 100170. [Google Scholar] [CrossRef]
- Brahmi, N.; Blel, Y.; Abidi, N.; Kouraichi, N.; Thabet, H.; Hedhili, A.; Amamou, M. Methanol poisoning in Tunisia: Report of 16 cases. Clin. Toxicol. 2007, 45, 717–720. [Google Scholar] [CrossRef]
- Md Noor, J.; Hawari, R.; Mokhtar, M.F.; Yussof, S.J.; Chew, N.; Norzan, N.A.; Rahimi, R.; Ismail, Z.; Singh, S.; Baladas, J.; et al. Methanol outbreak: A Malaysian tertiary hospital experience. Int. J. Emerg. Med. 2020, 13, 6. [Google Scholar] [CrossRef]
- Eskandrani, R.; Almulhim, K.; Altamimi, A.; Alhaj, A.; Alnasser, S.; Alawi, L.; Aldweikh, E.; Alaufi, K.; Mzahim, B. Methanol poisoning outbreak in Saudi Arabia: A case series. J. Med. Case Rep. 2022, 16, 357. [Google Scholar] [CrossRef]
- Paasma, R.; Hovda, K.E.; Tikkerberi, A.; Jacobsen, D. Methanol mass poisoning in Estonia: Outbreak in 154 patients. Clin. Toxicol. 2007, 45, 152–157. [Google Scholar] [CrossRef]
- Sodhi, P.K.; Goyal, J.L.; Mehta, D.K. Methanol-induced optic neuropathy: Treatment with intravenous high dose steroids. Int. J. Clin. Pract. 2001, 55, 599–602. [Google Scholar] [CrossRef]
- Desai, T.; Sudhalkar, A.; Vyas, U.; Khamar, B. Methanol poisoning: Predictors of visual outcomes. JAMA Ophthalmol. 2013, 131, 358–364. [Google Scholar] [CrossRef] [Green Version]
- Simani, L.; Ramezani, M.; Roozbeh, M.; Shadnia, S.; Pakdaman, H. The outbreak of methanol intoxication during COVID-19 pandemic: Prevalence of brain lesions and its predisposing factors. Drug Chem. Toxicol. 2020, 45, 1500–1503. [Google Scholar] [CrossRef]
- National Center for Biotechnology Information. “PubChem Compound Summary for CID 887, Methanol” PubChem. Available online: https://pubchem.ncbi.nlm.nih.gov/compound/Methanol (accessed on 28 May 2023).
- American Academy of Clinical Toxicology Ad Hoc Committee on the Treatment Guidelines for Methanol Poisoning; Barceloux, D.G.; Randall Bond, G.; Krenzelok, E.P.; Cooper, H.; Allister Vale, J. American Academy of Clinical Toxicology Practice Guidelines on the Treatment of Methanol Poisoning. J. Toxicol. Clin. Toxicol. 2002, 40, 415–446. [Google Scholar] [CrossRef]
- Brubaker, R.H.; Vashisht, R.; Meseeha, M. High Anion Gap Metabolic Acidosis. In StatPearls; StatPearls Publishing: Treasure Island, FL, USA, 2023. [Google Scholar]
- Najari, F.; Baradaran, I.; Najari, D. Methanol Poisoning and Its Treatment. Int. J. Med. Toxicol. Forensic Med. 2020, 10, 26639. [Google Scholar] [CrossRef] [Green Version]
- Holzman, S.D.; Larsen, J.; Kaur, R.; Smelski, G.; Dudley, S.; Shirazi, F.M. Death by hand sanitizer: Syndemic methanol poisoning in the age of COVID-19. Clin. Toxicol. 2021, 59, 1009–1014. [Google Scholar] [CrossRef]
- Brent, J. Fomepizole for ethylene glycol and methanol poisoning. N. Engl. J. Med. 2009, 360, 2216–2223. [Google Scholar] [CrossRef] [Green Version]
- Rietjens, S.J.; De Lange, D.W.; Meulenbelt, J. Ethylene glycol or methanol intoxication: Which antidote should be used, fomepizole or ethanol. Neth. J. Med. 2014, 72, 73–79. [Google Scholar]
- McMartin, K.; Jacobsen, D.; Hovda, K.E. Antidotes for poisoning by alcohols that form toxic metabolites. Br. J. Clin. Pharmacol. 2016, 81, 505–515. [Google Scholar] [CrossRef] [Green Version]
- Ashurst, J.V.; Nappe, T.M. Methanol Toxicity. In StatPearls; StatPearls Publishing: Treasure Island, FL, USA, 2023. [Google Scholar]
- Chan, A.P.L.; Chan, T.Y.K. Methanol as an Unlisted Ingredient in Supposedly Alcohol-Based Hand Rub Can Pose Serious Health Risk. Int. J. Env. Res. Public Health 2018, 15, 1440. [Google Scholar] [CrossRef] [Green Version]
- Holt, N.R.; Nickson, C.P. Severe methanol poisoning with neurological sequelae: Implications for diagnosis and management. Intern Med. J. 2018, 48, 335–339. [Google Scholar] [CrossRef]
- Jobard, E.; Harry, P.; Turcant, A.; Marie Roy, P.; Allain, P. 4-Methylpyrazole and hemodialysis in ethylene glycol poisoning. J. Toxicol. Clin. Toxicol. 1996, 34, 373–377. [Google Scholar] [CrossRef]
- Chen, T.-H.; Kuo, C.-H.; Huang, C.-T.; Wang, W.-L. Use of Fomepizole in Pediatric Methanol Exposure: The First Case Report in Taiwan and a Literature Review. Pediatr. Neonatol. 2016, 57, 351–354. [Google Scholar] [CrossRef] [Green Version]
- Ukita, K.; Otomune, K.; Fujimoto, R.; Hasegawa, K.; Izumikawa, K.; Morimoto, N.; Sasaki, K.; Hirasaki, A.; Takaguchi, K. Anion gap-opening metabolic acidosis and urinary findings in the early diagnosis of ethylene glycol poisoning: A case report. Clin. Case Rep. 2022, 10, e05215. [Google Scholar] [CrossRef]
- Kute, V.B.; Godara, S.M.; Shah, P.R.; Gumber, M.R.; Goplani, K.R.; Vanikar, A.V.; Munjappa, B.C.; Patel, H.V.; Trivedi, H.L. Hemodialysis for methyl alcohol poisoning: A single-center experience. Saudi J. Kidney Dis. Transpl. 2012, 23, 37–43. [Google Scholar]
- Mirrakhimov, A.E.; Ayach, T.; Barbaryan, A.; Talari, G.; Chadha, R.; Gray, A. The Role of Sodium Bicarbonate in the Management of Some Toxic Ingestions. Int. J. Nephrol. 2017, 2017, 7831358. [Google Scholar] [CrossRef] [Green Version]
- Williams, G.F.; Hatch, F.J.; Bradley, M.C. Methanol poisoning: A review and case study of four patients from Central Australia. Aust. Crit. Care 1997, 10, 113–118. [Google Scholar] [CrossRef]
- Sevimli, H.; Yönak, H.; Beleli, G.; Akça, H.Ş.; Özdemir, S.; Algın, A.; Eroğlu, S.E. Death also have color, this time purple; Methanol. Balıkesir Med. J. 2020, 4, 29–33. [Google Scholar] [CrossRef]
- Mallick, U.K.; Shahid, S.M.H.; Faruq, M.O.; Asaduzzaman, M.; Sultana, A.; Asha, A. Rrefractory Metabolic Acidosis in a Diabetic Patient: A case of Unsuspected Methanol Intoxication. Bangladesh Crit. Care J. 2019, 7, 111–112. [Google Scholar] [CrossRef]
- Zakharov, S.; Pelclova, D.; Urban, P.; Navratil, T.; Nurieva, O.; Kotikova, K.; Diblik, P.; Kurcova, I.; Belacek, J.; Komarc, M. Use of out-of-hospital ethanol administration to improve outcome in mass methanol outbreaks. Ann. Emerg. Med. 2016, 68, 52–61. [Google Scholar] [CrossRef]
- Nurieva, O.; Hubacek, J.A.; Urban, P.; Hlusicka, J.; Diblik, P.; Kuthan, P.; Sklenka, P.; Meliska, M.; Bydzovsky, J.; Heissigerova, J. Clinical and genetic determinants of chronic visual pathway changes after methanol-induced optic neuropathy: Four-year follow-up study. Clin. Toxicol. 2019, 57, 387–397. [Google Scholar] [CrossRef]
- Zakharov, S.; Pelclova, D.; Diblik, P.; Urban, P.; Kuthan, P.; Nurieva, O.; Kotikova, K.; Navratil, T.; Komarc, M.; Belacek, J. Long-term visual damage after acute methanol poisonings: Longitudinal cross-sectional study in 50 patients. Clin. Toxicol. 2015, 53, 884–892. [Google Scholar] [CrossRef]
Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | Patient 6 | |
---|---|---|---|---|---|---|
Gender | Male | Male | Male | Male | Male | Male |
Age in years | 43 | 26 | 44 | 41 | 32 | 30 |
Nationality | Saudi | Indian | Saudi | Nepalese | Indian | Indian |
Hospital admission date | 16 November 2022 | 16 November 2022 | 16 November 2022 | 4 March 2022 | 4 March 2022 | 4 March 2022 |
Hospital duration | 10 h | 12 h | 10 h | 5 d | 3 d | 3 d |
Exposure | Alcohol history | Alcohol history | Colonia ingestion | Alcohol ingestion (colonia) | Alcohol ingestion | Alcohol ingestion (colonia) |
Methanol poisoning | Yes | Yes | Yes | Yes | Yes | Yes |
Methanol level (mg/dL) | NA | 275 | NA | NA | NA | NA |
Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | Patient 6 | |
---|---|---|---|---|---|---|
Pulse (beats/min) | 101 | 80 | 138 | 62 | 96 | 82 |
RR (respirations/min) | 20 | 20 | 22 | 20 | 20 | 20 |
BP (mm.Hg) | 79/64 | 98/48 | 170/116 | 133/90 | 143/87 | 145/95 |
Temp (°C) | 37 | 37 | 34.7 | 36.6 | 36.6 | 38.2 |
SPO2 (%) | 100 | 100 | 99 | 90 | 96 | 95 |
PCO2 (mm.Hg) | 45.9 | 54.2 | 19 | 36.4 | 28 | 25 |
Arterial pH | 6.56 | 6.8 | 7 | 7.19 | 7.1 | 7.1 |
HCO3 (mmol/L) | 1.7 | 1 | 4 | 10 | 11.2 | 8.5 |
TLC | 18.8 | 8.47 | NA | NA | NA | NA |
Hgb (g/dL) | 14.8 | 16 | 16.4 | 13 | 17.1 | 16 |
WBC (g/L) | 18.8 | 12.24 | 11.9 | 6.34 | 14.1 | 17 |
PLT (g/L) | 206 | 151 | 342 | 355 | 307 | 389 |
INR | 1.1 | NA | 1.1 | 1.14 | 1.08 | NA |
AST (U/L) | 173 | 446 | 48 | 41 | 35 | 19 |
ALT (U/L) | 82 | 116 | 81 | 59 | 29 | 12 |
ALP (U/L) | 106 | 61 | 109 | NA | 103 | 109 |
Direct bilirubin (mg/dL) | 0.16 | 0.46 | 0.14 | 0.2 | 0.2 | 0.3 |
T.protein (g/dL) | 5.9 | 5 | NA | 6.3 | 6.6 | 6.6 |
Albumin (g/dL) | 3.6 | 2.6 | 3.7 | 3.5 | 3.5 | 3.6 |
T.bilirubin (mg/dL) | 0.2 | 0.6 | 0.3 | 0.7 | 0.7 | 0.7 |
λGT (U/L) | 111 | 155 | NA | 137 | 30 | 58 |
RBS (mg/dL) | 151 | 207 | 261 | 117 (FBS) | 64 | 81 |
LDH (U/L) | 510 | NA | 250 | NA | NA | NA |
Mg (mg/dL) | NA | 2.55 | 1.59 | NA | NA | 1.7 |
Ca (mg/dL) | 7.8 | 9.4 | 9.1 | 8.4 | 5.8 | 8.6 |
Na (mmol/L) | 142 | 160 | 143 | 139 | 134 | 142 |
K (mmol/L) | 4.4 | 1.4 | 3.2 | 3.4 | 3.2 | 3.2 |
Cl (mmol/L) | 111 | 122 | 109 | 107 | 103 | 113 |
Osmolality serum (Mosmol/kg) | 283.5 | 312 | 329 | 274.85 | 260.7 | 283.9 |
Cr (mg/dL) | 1.36 | 1.38 | 1.11 | 0.7 | 0.73 | 0.77 |
Urea (mg/dL) | 27.82 | 27.8 | 26.2 | 14.98 | 34 | 23.54 |
Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | Patient 6 | |
---|---|---|---|---|---|---|
Eye: | ||||||
| Dilated | Dilated | Dilated | Dilated with sluggish response | Dilated | Dilated |
| Visual loss | Non-reactive to light | Lost left eye | Toxic optic nerve damage | Toxic optic nerve damage | Toxic optic nerve damage and blurred vision |
Heart | Arrest | Arrest | Tachycardia, arrest | Normal | Normal | Normal |
Respiratory | Normal | Mechanical ventilation | Gasping breath, arrest | Normal | Normal | Normal |
Temp | Normal | Normal | Hypothermic | Normal | Normal | Fever |
Metabolic acidosis | Yes | Yes | Yes | Yes | Yes | Yes |
Abdomen | Normal | Soft, no megally | Pain, soft, coffee vomit | Soft lax | Soft lax, epigastric pain, vomiting | Soft lax |
Kidney | Acute renal failure | NA | NA | NA | NA | NA |
CNS: | ||||||
| Diffused edema, anorexic damage | Normal | Normal | Normal | Normal | Normal |
| Yes | Yes | Yes | Yes | Yes | Yes |
| NA | Yes | Yes | NA | NA | NA |
| Yes | Yes | Yes | No, drowsy | No | No, drowsy |
Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | Patient 6 | |
---|---|---|---|---|---|---|
IV normal saline (D5NS 100 mL/h) | + | + | + | + | + | + |
Sodium bicarbonate infusion | + | + | + | + | + | + |
Plasma protein fraction infusion | + | - | - | - | - | - |
Hemodialysis | - | - | - | + | + | + |
Mechanical ventilation | + | + | + | - | - | - |
40 mEq KCl IV Intravenous infusion in 500 mL NSS over 4 or 6 h | + | + | + | + | + | + |
Fomepizole 15 mg/kg IV as loading sode | - | - | - | + | + | + |
Fomepizole 10 mg/kg IV 4 doses/2 days | - | - | - | + | + | + |
Thiamine 100 mg IV/stat | - | - | - | + | + | + |
Ethanol 600 mg/kg IV infusion | - | - | +- | - | - | - |
Omeprazole 40 mg IV daily | + | + | + | + | + | + |
Ranitidine 50 mg IV/stat | - | - | + | - | - | - |
Diazepam 3 mg IV/stat | - | + | + | - | - | - |
sc enoxaparin 4000 iu once a day | + | + | - | - | + | + |
Vasopressor noradrenaline | + | + | + | - | - | - |
Dopamine HCL 40 mcg/kg every 1 h | + | - | - | - | - | - |
Potassium phosphate 21 mmol/day IV | - | + | + | - | - | - |
Magnesium sulphate 2 g/day IV | - | + | + | - | - | - |
KCl 600 mg tab tid PO | - | - | - | - | + | + |
Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | Patient 6 | |
---|---|---|---|---|---|---|
AG (mmol/L) | 33.7 | 38.4 | 33.2 | 25.4 | 23 | 23.7 |
Mean ± SD | 33.7 ± 2.87 (died) | 23.7 ± 1.23 (survived) | ||||
p-value | 0.037 (sig) | |||||
OG (mmol/kg) | −18.8 | −29.4 | 19.1 | −15.0 | −23.31 | −13 |
Mean ± SD | 19.10 ± 6.04 (died) | 15 ± 5.47 (survived) | ||||
p-value | 0.024 (sig) |
Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | Patient 6 | |
---|---|---|---|---|---|---|
Outcome | Dead | Dead | Dead | Improved | Improved | Improved |
Causes of death | Post-cardiac arrest | Post-cardiac arrest | Post-cardiac arrest | No | No | No |
Anorexic brain damage | Pulmonary arrest | Pulmonary arrest |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Alqurashi, G.I.; Alqurashi, F.S.; Alhusayni, K.M.; Falemban, A.H.; Alhindi, Y.Z.; Alsanosi, S.M.; Alzahrani, A.R.; Al-Ghamdi, S.S.; Ayoub, N. Case Reports Study on Methanol Poisoning in King Abdul Aziz Specialist Hospital, Taif, Saudi Arabia. J. Clin. Med. 2023, 12, 4282. https://doi.org/10.3390/jcm12134282
Alqurashi GI, Alqurashi FS, Alhusayni KM, Falemban AH, Alhindi YZ, Alsanosi SM, Alzahrani AR, Al-Ghamdi SS, Ayoub N. Case Reports Study on Methanol Poisoning in King Abdul Aziz Specialist Hospital, Taif, Saudi Arabia. Journal of Clinical Medicine. 2023; 12(13):4282. https://doi.org/10.3390/jcm12134282
Chicago/Turabian StyleAlqurashi, Ghadi I., Fahad S. Alqurashi, Khalid M. Alhusayni, Alaa H. Falemban, Yosra Z. Alhindi, Safaa M. Alsanosi, Abdullah R. Alzahrani, Saeed S. Al-Ghamdi, and Nahla Ayoub. 2023. "Case Reports Study on Methanol Poisoning in King Abdul Aziz Specialist Hospital, Taif, Saudi Arabia" Journal of Clinical Medicine 12, no. 13: 4282. https://doi.org/10.3390/jcm12134282
APA StyleAlqurashi, G. I., Alqurashi, F. S., Alhusayni, K. M., Falemban, A. H., Alhindi, Y. Z., Alsanosi, S. M., Alzahrani, A. R., Al-Ghamdi, S. S., & Ayoub, N. (2023). Case Reports Study on Methanol Poisoning in King Abdul Aziz Specialist Hospital, Taif, Saudi Arabia. Journal of Clinical Medicine, 12(13), 4282. https://doi.org/10.3390/jcm12134282